$5.89
-0.06-1.01%
At close: Sep 4, 5:00 PM EST
$5.89
N/A
After Hours: Sep 4, 4:01 PM EST
AN2 Therapeutics Inc
ANTXNASDAQ
AN2 Therapeutics Earnings & Forecasts
AN2 Therapeutics (ANTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AN2 Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.23 | $-0.24 | $-0.22 |
| Actual | $-0.18 | $-0.29 | $-0.29 | $-0.31 |
| Surprise | +25.0% | -26.1% | -20.8% | -40.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.20 | $-0.23 |
| Revenue | ||
| Consensus | — | — |
